Figure 6

Cardiomyopathies - The special entity of myocarditis and inflammatory cardiomyopathy

Felicitas Escher*, Uwe Kühl, Dirk Lassner and Heinz-Peter Schultheiss

Published: 01 July, 2019 | Volume 4 - Issue 2 | Pages: 053-070

Hemodynamic course of patients with virus-negative inflammatory cardiomyopathy treated immunosuppressive at baseline, 6 months and at a long-term follow-up period.
We analyzed the hemodynamic course of 87 patients after 6 months and in long-term follow-ups subsequent to immunosuppressive therapy: 1 mg/kg body weight daily of prednisone for 4 weeks followed by 0.33 mg/kg body weight daily for 5 months and azathioprine 2 mg/kg body weight daily for 6 months.
Immunosuppressive treatment of patients with virus-negative infl ammatory cardiomyopathy resulted in A) an improvement of LVEF in long-term follow-up with significantly reduction of intramyocardial infl ammation B) CD3 positive t-cells, C) cytotoxic cells (perforin) in 6 month EMB.
Mean values ± standard deviation are shown; **P< 0.0001, *P< 0.05 (compared to baseline EMB)

" alt="jccm-aid1041-g006"class="img-responsive img-rounded " style="cursor:pointer">

Figure 6:

Hemodynamic course of patients with virus-negative inflammatory cardiomyopathy treated immunosuppressive at baseline, 6 months and at a long-term follow-up period.
We analyzed the hemodynamic course of 87 patients after 6 months and in long-term follow-ups subsequent to immunosuppressive therapy: 1 mg/kg body weight daily of prednisone for 4 weeks followed by 0.33 mg/kg body weight daily for 5 months and azathioprine 2 mg/kg body weight daily for 6 months.
Immunosuppressive treatment of patients with virus-negative infl ammatory cardiomyopathy resulted in A) an improvement of LVEF in long-term follow-up with significantly reduction of intramyocardial infl ammation B) CD3 positive t-cells, C) cytotoxic cells (perforin) in 6 month EMB.
Mean values ± standard deviation are shown; **P< 0.0001, *P< 0.05 (compared to baseline EMB)

Read Full Article HTML DOI: 10.29328/journal.jccm.1001041 Cite this Article Read Full Article PDF

More Images

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More